Evaluation of two Massive Open Online Courses (MOOCs) in genomic variant interpretation for the NHS workforce.

Cancer genomics Genomic variants Genomics education MOOCs Online learning

Journal

BMC medical education
ISSN: 1472-6920
Titre abrégé: BMC Med Educ
Pays: England
ID NLM: 101088679

Informations de publication

Date de publication:
28 Jul 2023
Historique:
received: 18 10 2022
accepted: 26 05 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

The implementation of the National Genomic Medicine Service in the UK has increased patient access to germline genomic testing. Increased testing leads to more genetic diagnoses but does result in the identification of genomic variants of uncertain significance (VUS). The rigorous process of interpreting these variants requires multi-disciplinary, highly trained healthcare professionals (HCPs). To meet this training need, we designed two Massive Open Online Courses (MOOCs) for HCPs involved in germline genomic testing pathways: Fundamental Principles (FP) and Inherited Cancer Susceptibility (ICS). An evaluation cohort of HCPs involved in genomic testing were recruited, with additional data also available from anonymous self-registered learners to both MOOCs. Pre- and post-course surveys and in-course quizzes were used to assess learner satisfaction, confidence and knowledge gained in variant interpretation. In addition, granular feedback was collected on the complexity of the MOOCs to iteratively improve the resources. A cohort of 92 genomics HCPs, including clinical scientists, and non-genomics clinicians (clinicians working in specialties outside of genomics) participated in the evaluation cohort. Between baseline and follow-up, total confidence scores improved by 38% (15.2/40.0) (95% confidence interval [CI] 12.4-18.0) for the FP MOOC and 54% (18.9/34.9) (95%CI 15.5-22.5) for the ICS MOOC (p < 0.0001 for both). Of those who completed the knowledge assessment through six summative variant classification quizzes (V1-6), a mean of 79% of respondents classified the variants such that correct clinical management would be undertaken (FP: V1 (73/90) 81% Likely Pathogenic/Pathogenic [LP/P]; V2 (55/78) 70% VUS; V3 (59/75) 79% LP/P; V4 (62/72) 86% LP/LP. ICS: V5 (66/91) 73% VUS; V6 (76/88) 86% LP/P). A non-statistically significant higher attrition rate was seen amongst the non-genomics workforce when compared to genomics specialists for both courses. More participants from the non-genomics workforce rated the material as "Too Complex" (FP n = 2/7 [29%], ICS n = 1/5 [20%]) when compared to the specialist genomics workforce (FP n = 1/43 [2%], ICS n = 0/35 [0%]). After completing one or both MOOCs, self-reported confidence in genomic variant interpretation significantly increased, and most respondents could correctly classify variants such that appropriate clinical management would be instigated. Genomics HCPs reported higher satisfaction with the level of content than the non-genomics clinicians. The MOOCs provided foundational knowledge and improved learner confidence, but should be adapted for different workforces to maximise the benefit for clinicians working in specialties outside of genetics.

Sections du résumé

BACKGROUND BACKGROUND
The implementation of the National Genomic Medicine Service in the UK has increased patient access to germline genomic testing. Increased testing leads to more genetic diagnoses but does result in the identification of genomic variants of uncertain significance (VUS). The rigorous process of interpreting these variants requires multi-disciplinary, highly trained healthcare professionals (HCPs). To meet this training need, we designed two Massive Open Online Courses (MOOCs) for HCPs involved in germline genomic testing pathways: Fundamental Principles (FP) and Inherited Cancer Susceptibility (ICS).
METHODS METHODS
An evaluation cohort of HCPs involved in genomic testing were recruited, with additional data also available from anonymous self-registered learners to both MOOCs. Pre- and post-course surveys and in-course quizzes were used to assess learner satisfaction, confidence and knowledge gained in variant interpretation. In addition, granular feedback was collected on the complexity of the MOOCs to iteratively improve the resources.
RESULTS RESULTS
A cohort of 92 genomics HCPs, including clinical scientists, and non-genomics clinicians (clinicians working in specialties outside of genomics) participated in the evaluation cohort. Between baseline and follow-up, total confidence scores improved by 38% (15.2/40.0) (95% confidence interval [CI] 12.4-18.0) for the FP MOOC and 54% (18.9/34.9) (95%CI 15.5-22.5) for the ICS MOOC (p < 0.0001 for both). Of those who completed the knowledge assessment through six summative variant classification quizzes (V1-6), a mean of 79% of respondents classified the variants such that correct clinical management would be undertaken (FP: V1 (73/90) 81% Likely Pathogenic/Pathogenic [LP/P]; V2 (55/78) 70% VUS; V3 (59/75) 79% LP/P; V4 (62/72) 86% LP/LP. ICS: V5 (66/91) 73% VUS; V6 (76/88) 86% LP/P). A non-statistically significant higher attrition rate was seen amongst the non-genomics workforce when compared to genomics specialists for both courses. More participants from the non-genomics workforce rated the material as "Too Complex" (FP n = 2/7 [29%], ICS n = 1/5 [20%]) when compared to the specialist genomics workforce (FP n = 1/43 [2%], ICS n = 0/35 [0%]).
CONCLUSIONS CONCLUSIONS
After completing one or both MOOCs, self-reported confidence in genomic variant interpretation significantly increased, and most respondents could correctly classify variants such that appropriate clinical management would be instigated. Genomics HCPs reported higher satisfaction with the level of content than the non-genomics clinicians. The MOOCs provided foundational knowledge and improved learner confidence, but should be adapted for different workforces to maximise the benefit for clinicians working in specialties outside of genetics.

Identifiants

pubmed: 37507729
doi: 10.1186/s12909-023-04406-x
pii: 10.1186/s12909-023-04406-x
pmc: PMC10386229
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

540

Subventions

Organisme : Cancer Research UK
ID : 27223
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C61296/A27223
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

BMC Cancer. 2015 Nov 25;15:936
pubmed: 26608569
J Med Genet. 2021 May;58(5):297-304
pubmed: 33208383
Fam Cancer. 2019 Jul;18(3):293-301
pubmed: 30689103
BMC Med Educ. 2018 May 16;18(1):111
pubmed: 29769059
J Med Internet Res. 2014 Aug 14;16(8):e191
pubmed: 25123952
Fam Cancer. 2019 Jan;18(1):121-126
pubmed: 29721668
Nurse Educ Today. 2021 Apr;99:104812
pubmed: 33610051
BMJ Open Qual. 2021 Mar;10(1):
pubmed: 33674343
J Educ Health Promot. 2020 Aug 31;9:195
pubmed: 33062728
Ann Epidemiol. 2017 Sep;27(9):611-615
pubmed: 28844550
BMC Med Educ. 2019 Sep 14;19(1):356
pubmed: 31521150
Nurse Educ Today. 2019 May;76:96-102
pubmed: 30776535
Genet Med. 2021 Jul;23(7):1356-1365
pubmed: 33824503
Clin Med (Lond). 2023 Jan;23(1):9-15
pubmed: 36697012
Clin Med (Lond). 2019 Jul;19(4):273-277
pubmed: 31308102
BMC Med Educ. 2021 Dec 1;21(1):595
pubmed: 34852801
Medicine (Baltimore). 2021 Mar 5;100(9):e24829
pubmed: 33655944
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Front Genet. 2019 Nov 13;10:1094
pubmed: 31798624
Med Teach. 2017 Jul;39(7):691-696
pubmed: 28485629
Clin Med (Lond). 2019 Jul;19(4):269-272
pubmed: 31308101
PLoS One. 2021 Apr 16;16(4):e0250241
pubmed: 33861799
J Genet Couns. 2021 Dec;30(6):1559-1569
pubmed: 33969574
BMJ Open. 2019 Oct 22;9(10):e030505
pubmed: 31640999

Auteurs

Beth Coad (B)

St George's University of London, London, UK. bcoad@sgul.ac.uk.

Katherine Joekes (K)

St George's University of London, London, UK.

Alicja Rudnicka (A)

St George's University of London, London, UK.

Amy Frost (A)

National Genomics Education, NHS England, London, UK.

Mark Robert Openshaw (MR)

Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK.

Katrina Tatton-Brown (K)

National Genomics Education, NHS England, London, UK.

Katie Snape (K)

St George's University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH